| NCT ID | NCT06801756 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Craniopharyngioma |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-24 |
| Primary Completion | 2026-03-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-24 with a primary completion date of 2026-03-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Craniopharyngiomas (CP) are rare hypothalamic-pituitary tumors found in young children, adolescents and adults. The management of PC remains complex, as their aggressive nature, invasive behavior and propensity to recur require sequential and balanced therapeutic attitudes, as well as follow-up in an expert center. Although patient survival rates are high, the consequences of the tumor and its treatment can lead to serious comorbidities and impaired quality of life, particularly in patients whose tumors extend to the hypothalamus. There is very little literature describing the outcome of pregnancy in craniopharyngioma patients and its impact on the craniopharyngioma. The largest study describes 6 women, mean age 24, who had a craniopharyngioma in childhood. Half of them had induced pregnancies; there is a succinct description of pregnancy complications and outcomes, as well as tumor progression. In the endocrinology department of Pitié Salpêtrière hospital, the investigators regularly follow over a hundred patients of all ages who have presented with a craniopharyngioma in childhood or adulthood. They are also unique in having a medically assisted reproduction unit, which helps couples to realize their parental project. This dual specialization will enable to describe pregnancies and their impact on the behavior of craniopharyngiomas.
Eligibility Criteria
Inclusion Criteria: * Patients aged at least 18 years old * Patients with or having had a craniopharyngioma * Patients informed and not opposed to participation in research Exclusion Criteria: * Patients who don't speak french * Patients without medical care insurance * Patients under legal protection
Contact & Investigator
Anne BACHELOT, MD, PhD
STUDY CHAIR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT06801756 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Craniopharyngioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06801756 currently recruiting?
Yes, NCT06801756 is actively recruiting participants. Contact the research team at anne.bachelot@aphp.fr for enrollment information.
Where is the NCT06801756 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06801756 clinical trial?
NCT06801756 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Anne BACHELOT, MD, PhD at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 100 participants.